...
首页> 外文期刊>British Journal of Pharmacology >The intravenous administration of tumor necrosis factor alpha, interleukin 8 and macrophage-derived neutrophil chemotactic factor inhibits neutrophil migration by stimulating nitric oxide production
【24h】

The intravenous administration of tumor necrosis factor alpha, interleukin 8 and macrophage-derived neutrophil chemotactic factor inhibits neutrophil migration by stimulating nitric oxide production

机译:静脉注射肿瘤坏死因子α,白介素8和巨噬细胞衍生的中性粒细胞趋化因子通过刺激一氧化氮的产生抑制中性粒细胞的迁移

获取原文
获取原文并翻译 | 示例
           

摘要

The i.v. administration of tumor necrosis factor-α(TNF-α), interleukin-8(IL-8) and the recently described macrophage-derived neutrophil chemotactic factor (MNCF) inhibits the recruitment of neutrophils to the inflammatory site. Pretreatment of mice with the NO synthase antagonist, N~G-monomethyl-L-arginine(L-NMMA, 15- 60 mg kg~-1), but not the inactive enantiomer D-NMMA(30 mg kg~-1), prevented in a dose-dependent manner the TNF-α, IL-8 and MNCF-mediated inhibition of neutrophil migration into thioglycollate- challenged peritoneal cavities.
机译:i.v.肿瘤坏死因子-α(TNF-α),白细胞介素-8(IL-8)和最近描述的巨噬细胞衍生的嗜中性粒细胞趋化因子(MNCF)的给药抑制嗜中性粒细胞募集至炎症部位。用NO合酶拮抗剂N〜G-单甲基-L-精氨酸(L-NMMA,15-60 mg kg〜-1)预处理小鼠,但不使用非活性对映体D-NMMA(30 mg kg〜-1)预处理,可以剂量依赖性的方式阻止TNF-α,IL-8和MNCF介导的嗜中性粒细胞迁移进入巯基乙酸盐挑战的腹膜腔。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号